Clinical trial
Autonomous AI for Diabetic Retinopathy Screening in Youth (AI-DR): A Randomized Control Trial
NCT05131451 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autonomous AI for Diabetic Retinopathy Screening in Youth (AI-DR): A Randomized Control Trial
- Lead sponsor
- Johns Hopkins University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 24, 2021
- Completion date
- December 31, 2022
- Enrollment
- 164 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes, type 2 diabetes